AtaiBeckley Inc. (ATAI)
Health Care ยท Pharmaceutical Preparations
AtaiBeckley Inc. (ATAI) is listed on Nasdaq, where its shares have traded since June 18, 2021. SentiSense covers AtaiBeckley Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Srinivas Rao is its chief executive officer. The company reports 99 employees, and its corporate website is www.ataibeckley.com.
About AtaiBeckley Inc.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Latest reported results
AtaiBeckley Inc. reported revenue of $1.7 million for Q2 FY2026, up 137.0% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 235 institutions reported holding ATAI, with 134.8 million shares worth $710.1 million in aggregate. The largest reported holders were BlackRock, Vanguard and Deep Track Capital. Of the 5 largest reported holders, all 5 added shares during the quarter.
More on ATAI
- ATAI sentiment: whether news and social coverage of AtaiBeckley Inc. leans bullish or bearish, and the stories driving it.
- ATAI ownership: all 235 reporting institutions, plus insider and congressional trades.
- ATAI financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for AtaiBeckley Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does AtaiBeckley Inc. do?
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments.
What sector is ATAI in?
SentiSense classifies AtaiBeckley Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does ATAI stock trade?
AtaiBeckley Inc. (ATAI) is listed on Nasdaq, where its shares have traded since June 18, 2021.
Who is the CEO of AtaiBeckley Inc.?
Srinivas Rao is the chief executive officer of AtaiBeckley Inc..